BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 6:43:04 AM | Browse: 253 | Download: 502
 |
Received |
|
2020-12-24 00:37 |
|
Peer-Review Started |
|
2020-12-24 00:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-04 02:50 |
|
Revised |
|
2021-05-12 10:51 |
|
Second Decision |
|
2021-07-05 05:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-06 07:14 |
|
Articles in Press |
|
2021-07-06 07:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-15 00:26 |
|
Typeset the Manuscript |
|
2021-08-19 15:16 |
|
Publish the Manuscript Online |
|
2021-08-23 06:43 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
GOECP/SEOR Guidelines on radiotherapy for malignant pleural mesothelioma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Javier Luna, Andrea Bobo, Joaquín José Cabrera-Rodriguez, María Pagola, Margarita Martín-Martín, María Ángeles González Ruiz, Miguel Montijano, Aurora Rodríguez, Lira Pelari-Mici, Almudena Corbacho, Marta Moreno and Felipe Couñago |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Javier Luna, MD, Staff Physician, Department of Radiation Oncology , Institute of Oncohealth, Fundación Jiménez Díaz, Avda, Reyes Católicos 2, Madrid 28040, Spain. jluna@fjd.es |
| Key Words |
Malignant pleural mesothelioma; Chemotherapy; Surgery; Radiotherapy; Radiation techniques; Reradiation |
| Core Tip |
Malignant pleural mesothelioma (MPM) is a rare tumor that is very challenging to treat. Technological advances in surgery and radiotherapy are largely responsible for the marginally improved outcomes observed in recent years. Heterogeneity among studies and a lack of phase III randomized controlled trials are some of the main barriers to achieving more effective, standardized treatments. In this review article, we provide an in-depth analysis of changes in the clinical, histologic, and therapeutic profile of MPM in recent decades and highlight the main research areas in this field. |
| Publish Date |
2021-08-23 06:43 |
| Citation |
Luna J, Bobo A, Cabrera-Rodriguez JJ, Pagola M, Martín-Martín M, Ruiz MÁG, Montijano M, Rodríguez A, Pelari-Mici L, Corbacho A, Moreno M, Couñago F. Oncological Group for the Study of Lung Cancer of the Spanish Society of Radiation Oncology Guidelines on radiotherapy for malignant pleural mesothelioma. World J Clin Oncol 2021; 12(8): 581-608 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i8/581.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i8.581 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
